Economy

Northrop Grumman to acquire Orbital ATK in deal worth $9.2 billion

Northrop Grumman to acquire Orbital ATK in deal worth $9.2 billion”

Aerospace manufacturer Orbital ATK soared 20 percent after agreeing to be acquired by Northrop Grumman.

Orbital shares surged over 19% to $131.51 after hours.

Also ion focus on Monday, Steelcase Inc (NYSE:SCS) shares added 1.79% on Friday ahead of today, where it is expected to post quarterly earnings of $0.23 per share on revenue of $759.83 million after the closing NY bell.

The Dow Jones industrial average rose 34 points, or 0.2 percent, to 22,301.

"Our complementary portfolios and technology-focused cultures will yield significant value creation through revenue synergies associated with new opportunities, cost savings, operational synergies, and enhanced growth", Northrop Grumman CEO Wes Bush said in a press release.

Northrop Grumman will purchase Orbital ATK with $7.8 billion in cash and assume $1.4 billion of Orbital's debt, the company's announced on Monday. Besides rockets that carry satellites to space, Orbital's businesses include rocket propulsion systems, missiles, defense electronics and precision weapons.



Like this

Latest


18 September 2017
Quebec father in Amber Alert case remains in hospital
The man appeared in an Ontario court on Saturday morning and was to be transferred back to Quebec later in the day. The man police are seeking to identify is described as standing five feet six inches tall and weighing 220 pounds.

18 September 2017
Christians, Muslims Unite to Protest Against Myanmar's Rohingya Crisis
The Buddhist-majority Myanmar government concentrated the Muslims in Rakhine state which have only a population of 1 million. The government has put the army in charge of ferrying foreign relief aid from airports to Cox's Bazar.

18 September 2017
Teva Pharma to sell some women's health assets for $1.38 bln
Sterneck Capital Management LLC boosted its stake in shares of Teva Pharmaceutical Industries Limited by 5.4% in the 2nd quarter. Finally, JFS Wealth Advisors LLC raised its stake in shares of Teva Pharmaceutical Industries by 139.0% in the third quarter.

18 September 2017
Everyone Wants To Play Against Tottenham Hotspur Admits Barnsley Star
Other players likely to be involved are 19-year-old Argentine defender Juan Foyth, Georges-Kevin N'Koudou and Harry Winks. Remember he was injured and then he had an operation and I think it was a tough season for him.

18 September 2017
Ford, Mahindra Group to explore strategic alliance
Indian carmaker Mahindra and Mahindra has entered into a partnership with American auto giant Ford Motors Company. From April to end-August this year, Ford sold 36,703 passenger cars in India compared with Mahindra's 96,051.

18 September 2017
Coutinho promises to 'give his best' at 'great club' Liverpool
The players, the directors, the technical staff. "I can not speak in this country about any players I tried to get", he said . That may not change too much with Coutinho back, although a Premier League ban for Mane comes at an unfortunate time.

18 September 2017
Chris Gayle becomes first batsman to hit 100 sixes in T20I
Plunkett is in store of becoming the leading wicket-taker in one-day internationals and looks set to break the record this year. He achieved the glorious moment during the T20 global match between West Indies and England recently.

18 September 2017
N. Korea: We'll speed up nuclear plans if more sanctions imposed
Seoul's Defense Ministry says two B-1Bs and four F-35Bs conducted drills with four South Korean F-15K fighter jets. Officials in Germany, which holds an election Sunday, have been adamant that there must be a diplomatic solution.

18 September 2017
LP Buys 534440 Shares of Acceleron Pharma Inc. (XLRN)
Lei Zhang increased its stake in Acceleron Pharma Inc (XLRN) by 66.67% based on its latest 2016Q4 regulatory filing with the SEC. The United Kingdom-based Aberdeen Asset Mgmt Public Ltd Liability Corp Uk has invested 0% in Acceleron Pharma Inc (NASDAQ:XLRN).

18 September 2017
Five Prime Therapeutics (FPRX) Getting Somewhat Favorable Media Coverage, Accern Reports
Traders are a little more bearish on shares of Five Prime Therapeutics, Inc . lately as shown by the motion in short interest. The Manufacturers Life Insurance Company raised its position in shares of Five Prime Therapeutics by 1.9% in the 2nd quarter.



Recommended